Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoxic Cancer Cells-Derived Exosomes Strengthen the Development of Cancer Stem Cell-Like Properties Through Delivering LINC00665 in Thyroid Cancer Cells. | Cell Biol Int | 2025 | 39831459 | PubTator, text mining | PubMed |
| Site-Specific Competitive Kinase Inhibitor Target Profiling Using Phosphonate Affinity Tags. | Mol Cell Proteomics | 2025 | 39826875 | PubTator, text mining | PubMed |
| Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis. | Biochemistry | 2025 | 39818753 | PubTator, text mining | PubMed |
| Swimming induces physiological cardioprotection associated with pro-growth versus anti-inflammatory influences in extracardiac organs. | Am J Physiol Regul Integr Comp Physiol | 2025 | 39792091 | PubTator, text mining | PubMed |
| Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation. | Nat Genet | 2025 | 39779956 | PubTator, text mining | PubMed |
| Biological function of EPHB4 in the aging process of vascular endothelial cells: mtDNA molecular mechanism and MAPK/PGC-1/TFAM signaling pathway. | Int J Biol Macromol | 2025 | 39653203 | PubTator, text mining | PubMed |
| Variations in RASA1 and EPHB4 in Chinese patients with capillary malformation-arteriovenous malformation. | J Dermatol | 2025 | 39578666 | PubTator, text mining | PubMed |
| Germline alteration analysis reveals EPHB4R91H mutation as a key player in multiple primary lung tumors. | Carcinogenesis | 2025 | 39574310 | PubTator, text mining | PubMed |
| Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC. | Oncogene | 2025 | 39489818 | PubTator, text mining | PubMed |
| Ets2 Exacerbates Diabetic Retinopathy by Aggravating the Proliferation of Endothelial Cells and Inflammatory Response. | Biochem Genet | 2025 | 39432129 | PubTator, text mining | PubMed |
| Second Report of the p.Leu874Pro Missense Variant in EPHB4 in a Family With Capillary Malformation-Arteriovenous Malformation Syndrome (CM-AVM) Syndrome. | Am J Med Genet A | 2025 | 39431828 | PubTator, text mining | PubMed |
| Non-fused Pyrimidine Derivatives as Potential Pharmacological Entities: A Review. | Curr Top Med Chem | 2025 | 39410888 | PubTator, text mining | PubMed |
| Genotypes and phenotypes of capillary malformation-arteriovenous malformation: characterization and correlation analysis. | Int J Dermatol | 2025 | 39367533 | PubTator, text mining | PubMed |
| Cerebrovascular Anomalies in the Fetus. | AJNR Am J Neuroradiol | 2025 | 38866434 | PubTator, text mining | PubMed |
| A review of electroacupuncture in bone repair: Mechanisms and clinical implications. | Medicine (Baltimore) | 2024 | 39809159 | PubTator, text mining | PubMed |
| Editorial: Molecular informatics in precision medicine. | Front Med (Lausanne) | 2024 | 39691365 | PubTator, text mining | PubMed |
| Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review. | Clin Case Rep | 2024 | 39498435 | PubTator, text mining | PubMed |
| IsRNAcirc: 3D structure prediction of circular RNAs based on coarse-grained molecular dynamics simulation. | PLoS Comput Biol | 2024 | 39466881 | PubTator, text mining | PubMed |
| EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis. | Circ Res | 2024 | 39421925 | PubTator, text mining | PubMed |
| Proteome-wide Mendelian randomization and single-cell sequencing analysis identify the association between plasma proteins and gastric cancer. | J Gastrointest Oncol | 2024 | 39279974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=6